Neutrophil transendothelial migration in vitro to Streptococcus pneumoniae is pneumolysin dependent

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 290, Issue 5, 2006, Pages

  Moreland, Jessica G ^a,b   Bailey, Gail ^a,b  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF IOWA   (United States)

Author keywords

Endothelial cells; Inflammation; Pneumonia; Virulence factors

Indexed keywords

ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 8; PNEUMOLYSIN; VASCULAR CELL ADHESION MOLECULE 1;

ARTICLE; BACTERIAL STRAIN; CELL MIGRATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; INCUBATION TIME; NEUTROPHIL; PRIORITY JOURNAL; STREPTOCOCCUS PNEUMONIAE; UPREGULATION; WILD TYPE;

BACTERIAL PROTEINS; CELL MOVEMENT; CELLS, CULTURED; COLONY-FORMING UNITS ASSAY; ENDOTHELIUM, VASCULAR; HUMANS; KINETICS; MICROCIRCULATION; NEUTROPHILS; PULMONARY CIRCULATION; STREPTOCOCCUS PNEUMONIAE; STREPTOLYSINS; VIRULENCE;

EID: 33646552749     PISSN: 10400605     EISSN: 15221504     Source Type: Journal    
DOI: 10.1152/ajplung.00333.2005     Document Type: Article

References (32)

1. Amory-Rivier CF, Mohler J, Bedos JP, Azoulay-Dupuis E, Henin D, Muffat-Joly M, Carbon C, and Moine P. Nuclear factor-κB activation in mouse lung lavage cells in response to Streptococcus pneumoniae pulmonary infection. Crit Care Med 28: 3249-3256, 2000.
2. Andonegui G, Bonder CS, Green F, Mullaly SC, Zbytnuik L, Raharjo E, and Kubes P. Endothelium-derived Toll-like receptor-4 is the key molecule in LPS-induced neutrophil sequestration into lungs. J Clin Invest 111: 1011-1020, 2003.
3. Berry A, Yother J, Briles D, Hansman D, and Paton J. Reduced virulence of a defined pneumolysin-negative mutant of Streptococcus pneumoniae. Infect Immun 57: 2037-2042, 1989.
4. Boyum A. Isolation of mononuclear cells and granulocytes from human blood. J Clin Lab Invest 21: 77-89, 1968.
5. Bullard DC, Qin L, Lorenzo I, Quinlin WM, Doyle NA, Bosse R, Vestweber D, Doerschuk CM, and Beaudet AL. P-selectin/ICAM-1 double mutant mice: acute emigration of neutrophils into the peritoneum is completely absent but is normal into pulmonary alveoli. J Clin Invest 95: 1782-1788, 1995.
6. Catterall J. Streptococcus pneumoniae. Thorax 54: 929-937, 1999.
7. Cundell D, Gerard N, Gerard C, Idanpaan-Heikkla I, and Tuomanen E. Streptococcus pneumoniae anchor to activated human cells by the receptor for platelet-activating factor. Nature 377: 435-438, 1995.
8. Gilbert R, Jimenez J, Chen S, Tickle I, Rossjohn J, Parker M, Andrew P, and Saibil H. Two structural transitions in membrane pore formation by pneumolysin, the pore-forming toxin of Streptococcus pneumoniae. Cell 97: 647-655, 1999.
9. Ishizuka S, Yamaya M, Suzuki T, Nakayama K, Kamanaka M, Ida S, Sekizawa K, and Sasaki H. Acid exposure stimulates the adherence of Streptococcus pneumoniae to cultured human airway epithelial cells: effects on platelet-activating factor receptor expression. Am J Respir Cell Mol Biol 24: 459-468, 2001.
10. Jounblat R, Kadioglu A, Mitchell TJ, and Andrew PW. Pneumococcal behavior and host responses during bronchopneumonia are affected differently by the cytolytic and complement-activating activities of pneumolysin. Infect Immun 71: 1813-1819, 2003.
11. Kadioglu A, Gingles NA, Grattan K, Kerr A, Mitchell TJ, and Andrew PW. Host cellular immune response to pneumococcal lung infection in mice. Infect Immun 68: 492-501, 2000.
12. Laterre PF, Garber G, Levy H, Wunderink R, Kinasewitz GT, Sollet JP, Maki DG, Bates B, Yan SC, and Dhainaut JF. Severe community-acquired pneumonia as a cause of severe sepsis: data from the PROWESS study. Crit Care Med 33: 952-961, 2005.
13. Malley R, Henneke P, Morse SC, Cieslewicz MJ, Lipsitch M, Thompson CM, Kurt-Jones E, Paton JC, Wessels MR, and Golenbock DT. Recognition of pneumolysin by Toll-like receptor 4 confers resistance to pneumococcal infections. Proc Natl Acad Sci USA 100: 1966-1971, 2003.
14. Mitchell T, Andrew P, Saunders F, Smith A, and Boulnois G. Complement activation and antibody binding by pneumolysin via a region of the toxin homologous to a human acute-phase protein. Mol Microbiol 5: 1883-1888, 1991.
15. Mizgerd JP, Meek BB, Kutkoski GJ, Bullard DC, Beaudet AL, and Doerschuk CM. Selectins and neutrophil traffic: margination and Streptococcus pneumoniae-induced emigration in murine lungs. J Exp Med 184: 639-645, 1996.
16. Moreland J, Bailey G, Nauseef WM, and Weiss JP. Organism-specific neutrophil-endothelial cell interactions in response to E. coli, S pneumoniae, and S aureus. J Immunol 172: 476-432, 2004.
17. Novak R and Tuomanen E. Pathogenesis of pneumococcal pneumonia. Semin Respir Infect 14: 209-217, 1999.
18. Opitz B, Puschel A, Schmeck B, Hocke AC, Rosseau S, Hammerschmidt S, Schumann RR, Suttorp N, and Hippenstiel S. Nucleotide-binding oligomerization domain proteins are innate immune receptors for internalized Streptococcus pneumoniae. J Biol Chem 279: 36426-36432, 2004.
19. Paton J. The contribution of pneumolysin to the pathogenicity of Streptococcus pneumoniae. Trends Microbiol 4: 103-106, 1996.
20. Pober JS. Effects of tumour necrosis factor and related cytokines on vascular endothelial cells. Ciba Found Symp 131: 170-184, 1987.
21. Rayner C, Jackson A, Rutman A, Dewar A, Mitchell T, Andrew P, Cole P, and Wilson R. Interaction of pneumolysin-sufficient and -deficient isogenic variants of Streptococcus pneumoniae with human respiratory mucosa. Infect Immun 63: 442-447, 1995.
22. Read MA, Whitley MZ, Williams AJ, and Collins T. NF-κB and IκBα: an inducible regulatory system in endothelial activation. J Exp Med 179: 503-512, 1994.
23. Ridger V, Wagner B, Wallace W, and Hellewell P. Differential effects of CD18, CD29, and CD49 integrin subunit inhibition on neutrophil migration in pulmonary inflammation. J Immunol 166: 3484-3490, 2001.
24. Rijneveld AW, van den Dobbelsteen GP, Florquin S, Standiford TJ, Speelman P, van Alphen L, and van der Poll T. Roles of interleukin-6 and macrophage inflammatory protein-2 in pneumolysin-induced lung inflammation in mice. J Infect Dis 185: 123-126, 2002.
25. Ring A, Weiser JN, and Tuomanen EI. Pneumococcal trafficking across the blood-brain barrier. J Clin Invest 102: 347-360, 1998.
26. Rubins J, Charboneau D, Paton J, Mitchell T, and Andrew P. Dual function of pneumolysin in the early pathogenesis of murine pneumococcal pneumonia. J Clin Invest 95: 142-150, 1995.
27. Spellerberg B, Rosenow C, Sha W, and Tuomanen EI. Pneumococcal cell wall activates NF-κB in human monocytes: aspects distinct from endotoxin. Microb Pathog 20: 309-317, 1996.
28. Steinfort C, Wilson R, Mitchell T, Feldman C, Rutman A, Todd H, Syke D, Walker J, Saunders K, and Andrew PW. Effects of Streptococcus pneumoniae on human respiratory epithelium in vitro. Infect Immun 57: 2006-2013, 1989.
29. Tan T. Update on pneumococcal infections of the respiratory tract. Semin Respir Infect 17: 3-9, 2002.
30. Tasaka S, Richer SE, Mizgerd JP, and Doerschuk CM. Very late antigen-4 in CD18-independent neutrophil emigration during acute bacterial pneumonia in mice. Am J Respir Crit Care Med 166: 53-60, 2002.
31. Weiss K, Low DE, Cortes L, Beaupre A, Gauthier R, Gregoire P, Legare M, Nepveu F, Thibert D, Tremblay C, and Tremblay J. Clinical characteristics at initial presentation and impact of dual therapy on the outcome of bacteremic Streptococcus pneumoniae pneumonia in adults. Can Respir J 11: 589-593, 2004.
32. Zysk G, Schneider-Wald B, Hwang J, Bejo L, Kim K, Mitchell T, Hakenbeck R, and Heinz HP. Pneumolysin is the main inducer of cytotoxicity to brain microvascular endothelial cells caused by Streptococcus pneumoniae. Infect Immun 69: 845-852, 2001.